225 related articles for article (PubMed ID: 7682093)
1. Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Kalifa C; Razafindrakoto H; Vassal G; Contesso G; Vanel D; Edeline V; Valteau D; Lemerle J
Cancer Treat Res; 1993; 62():347-9. PubMed ID: 7682093
[No Abstract] [Full Text] [Related]
2. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Ekert H; Tiedemann K
Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
[No Abstract] [Full Text] [Related]
3. A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Delepine N; Delepine G; Desbois JC
Cancer Treat Res; 1993; 62():327-32. PubMed ID: 7682092
[No Abstract] [Full Text] [Related]
4. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
[No Abstract] [Full Text] [Related]
5. The multi-institutional osteosarcoma study: an update.
Link MP
Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
[No Abstract] [Full Text] [Related]
6. Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Miser JS; Krailo M
Cancer Treat Res; 1993; 62():287-91. PubMed ID: 7682089
[No Abstract] [Full Text] [Related]
7. [Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Kalifa C; Mlika N; Dubousset J; Contesso G; Vanel D; Lumbroso J
Bull Cancer; 1988; 75(2):207-11. PubMed ID: 2451956
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
Meyers PA; Heller G; Vlamis V
Cancer Treat Res; 1993; 62():309-22. PubMed ID: 7682091
[No Abstract] [Full Text] [Related]
9. Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
Miser JS; Pritchard DJ; Rock MG; Shives TC; Gilchrist GS; Smithson WA; Arndt CA; Edmonson JH; Schaid DJ
Cancer Treat Res; 1993; 62():333-8. PubMed ID: 8096748
[No Abstract] [Full Text] [Related]
10. Results of therapy in osteosarcoma: experience in childrens hospitals in Buenos Aires.
Schvartzman E; Scopinaro M; Muriel FS
Cancer Treat Res; 1993; 62():351-3. PubMed ID: 8096750
[No Abstract] [Full Text] [Related]
11. An update of Scandinavian studies of osteosarcoma.
Elomaa I
Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
[No Abstract] [Full Text] [Related]
12. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
[TBL] [Abstract][Full Text] [Related]
14. Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
Pratt CB; Meyer WH; Rao BN; Parham DM; Fleming ID
Cancer Treat Res; 1993; 62():323-6. PubMed ID: 8096746
[No Abstract] [Full Text] [Related]
15. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
[No Abstract] [Full Text] [Related]
16. Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Shkalim-Zemer V; Ash S; Toledano H; Kollender Y; Issakov J; Yaniv I; Cohen IJ
Cancer Chemother Pharmacol; 2015 Nov; 76(5):909-16. PubMed ID: 26365289
[TBL] [Abstract][Full Text] [Related]
17. Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
Winkler K; Bieling P; Bielack S; Delling G; Dose C; Jürgens H; Kotz R; Ritter J; Salzer-Kuntschik M
Clin Orthop Relat Res; 1991 Sep; (270):79-86. PubMed ID: 1715820
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of osteosarcoma].
Winkler K; Bieling P; Bielack S
Z Orthop Ihre Grenzgeb; 1992; 130(4):285-9. PubMed ID: 1413973
[TBL] [Abstract][Full Text] [Related]
19. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
20. Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.
Cho Y; Jung GH; Chung SH; Kim JY; Choi Y; Kim JD
Clin Orthop Surg; 2011 Mar; 3(1):48-54. PubMed ID: 21369478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
